Drug eruption induced by IL-6 receptor inhibitor tocilizumab-Reference-Cited by-同舟云学术

Drug eruption induced by IL-6 receptor inhibitor tocilizumab

Published:2010-04 Issue:4 Volume:24 Page:495-496
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:

Author:

Yoshiki R,Nakamura M,Tokura Y

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-3083.2009.03437.x/fullpdf

Reference10 articles.

1. Resharping a human antibody to inhibit the interleukin 6-dependent tumor cell growth;Saato;Cancer Res,1993

2. Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study;Nishimoto;J Rheumatol,2003

3. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial;Nishimoto;Arthritis Rheum,2004

4. Phase II trial of anti-IL-6 receptor antibody (MRA) for systemic onset juvenle idiopathic arthritis;Yokota;Autoimmun Rev,2004

5. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease;Nishimoto;Blood,2005

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Interleukin-6 receptor antibody;Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology;2024-06-20

2. Leucocytoclastic vasculitis‐like reaction induced by tocilizumab in a patient with rheumatoid arthritis;Dermatologic Therapy;2022-11-15

3. Immune-related adverse events of biological immunotherapies used in COVID-19;Frontiers in Pharmacology;2022-08-25

4. Two Cases of Rheumatoid Arthritis with Cuataneous Leukocytoclastic Vasculitis Induced by Tocilizumab;Nishi Nihon Hifuka;2022-06-01

5. Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper;Allergy;2020-07